Patients’ Perception Towards Branded and Generic Medicines in an Emerging Economy: A Scale Development and Validation Study (Record no. 53226)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02586nam a2200217 4500 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | OSt |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20191213154046.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 191213b ||||| |||| 00| 0 eng d |
| 100 ## - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Alam, Md. Moddassir |
| 9 (RLIN) | 35377 |
| 245 ## - TITLE STATEMENT | |
| Title | Patients’ Perception Towards Branded and Generic Medicines in an Emerging Economy: A Scale Development and Validation Study |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 1292-1310 |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc | The study intends to develop and validate a scale to gauge the perception of patients towards branded and generic medicines in an emerging economy like India. Items were generated through literature review and exploratory semi-structured interview with patients and physicians. In the way of establishing generic medicines in the market, patients’ acceptability is very much essential. However, with the advent of information age, the patients are now becoming more conscious and aware regarding the generic medicines, and there is an improvement in the acceptability of generic medicines. Hence, the measurement of their perception towards generic medicines becomes an important issue for various stakeholders of the medical world—physicians, government, pharmaceutical companies and chemists. However, no studies regarding the measurement of perception towards the branded and generic have been conducted to develop and validate measurement scale. The present study is an attempt towards fulfilling this gap. A total of 361 valid responses were obtained using purposive sampling. Exploratory factor analysis (EFA) was carried out through principal component analysis (PCA) followed by confirmatory factor analysis (CFA) to establish the validity of the proposed measurement model. The five factors extracted from EFA were named as quality (Cronbach’s alpha: 0.887), trust (Cronbach’s alpha: 0.919), sustained effectiveness (Cronbach’s alpha: 0.832), reputation (Cronbach’s alpha: 0.881) and psychological benefits (Cronbach’s alpha: 0.737). The obtained factors were found reliable and valid for measuring perception of the patients towards generic and branded medicines in emerging market settings. Convergent and discriminant validity of the scale was also established. |
| 653 ## - INDEX TERM--UNCONTROLLED | |
| Uncontrolled term | Perception, branded medicine |
| Uncontrolled term | generic medicine |
| Uncontrolled term | exploratory factor analysis (EFA), |
| Uncontrolled term | confirmatory factor analysis (CFA) |
| 700 ## - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Mittal, Arun |
| 9 (RLIN) | 35378 |
| Personal name | Chawla,Deepak |
| 9 (RLIN) | 34103 |
| 773 0# - HOST ITEM ENTRY | |
| Host Biblionumber | 29349 |
| Host Itemnumber | 77622 |
| Main entry heading | BANIK, ARINDAM |
| Place, publisher, and date of publication | NEW DELHI SAGE PUBLISHING PVT. LTD. |
| Other item identifier | 55511230 |
| Title | GLOBAL BUSINESS REVIEW |
| International Standard Serial Number | 0972-1509 |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
| Source of classification or shelving scheme | Dewey Decimal Classification |
| Koha item type | Journal Article |
| Withdrawn status | Lost status | Source of classification or shelving scheme | Damaged status | Not for loan | Home library | Current library | Date acquired | Total Checkouts | Full call number | Barcode | Date last seen | Price effective from |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dewey Decimal Classification | Main Library | Main Library | 13/12/2019 | Vol 20, No 5 /55511230Ja12 | 55511230Ja12 | 13/12/2019 | 13/12/2019 |